S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022)

• Record Type: Journal Article
• Authors: Fernandez De Larrea, C.; González-Calle, V.; Oliver-Caldés, A.; Cabañas, V.; Rodríguez-Otero, P.; Español-Rego, M.; Reguera, J. L.; López-Corral, L.; Martin-Antonio, B.; Paiva, B.; Inogés, S.; Rosiñol, L.; López-Díaz de Cerio, A.; Tovar, N.; López-Parra, M.; Rodríguez-Lobato, L. G.; Sánchez-Salinas, A.; Varea, S.; Ortiz-Maldonado, V.; Pérez Simón, J. A.; Prósper, F.; Juan, M.; Moraleda, J. M.; Mateos, M. V.; Pascal, M.; Urbano-Ispizua, A.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 4
• Page End: 5
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000843308.71619.a0
• Languages: English
• ISSNs: 2572-9241